Literature DB >> 21873662

Retinal disease course in Usher syndrome 1B due to MYO7A mutations.

Samuel G Jacobson1, Artur V Cideciyan, Dan Gibbs, Alexander Sumaroka, Alejandro J Roman, Tomas S Aleman, Sharon B Schwartz, Melani B Olivares, Robert C Russell, Janet D Steinberg, Margaret A Kenna, William J Kimberling, Heidi L Rehm, David S Williams.   

Abstract

PURPOSE. To determine the disease course in Usher syndrome type IB (USH1B) caused by myosin 7A (MYO7A) gene mutations. METHODS. USH1B patients (n = 33, ages 2-61) representing 25 different families were studied by ocular examination, kinetic and chromatic static perimetry, dark adaptometry, and optical coherence tomography (OCT). Consequences of the mutant alleles were predicted. RESULTS. All MYO7A patients had severely abnormal ERGs, but kinetic fields revealed regional patterns of visual loss that suggested a disease sequence. Rod-mediated vision could be lost to different degrees in the first decades of life. Cone vision followed a more predictable and slower decline. Central vision ranged from normal to reduced in the first four decades of life and thereafter was severely abnormal. Dark adaptation kinetics was normal. Photoreceptor layer thickness in a wide region of central retina could differ dramatically between patients of comparable ages; and there were examples of severe losses in childhood as well as relative preservation in patients in the third decade of life. Comparisons were made between the mutant alleles in mild versus more severe phenotypes. CONCLUSIONS. A disease sequence in USH1B leads from generally full but impaired visual fields to residual small central islands. At most disease stages, there was preserved temporal peripheral field, a potential target for early phase clinical trials of gene therapy. From data comparing patients' rod disease in this cohort, the authors speculate that null MYO7A alleles could be associated with milder dysfunction and fewer photoreceptor structural losses at ages when other genotypes show more severe phenotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873662      PMCID: PMC3263772          DOI: 10.1167/iovs.11-8313

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  59 in total

1.  Three myosin V structures delineate essential features of chemo-mechanical transduction.

Authors:  Pierre-Damien Coureux; H Lee Sweeney; Anne Houdusse
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

2.  Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa.

Authors:  S G Jacobson; K Yagasaki; W J Feuer; A J Román
Journal:  Exp Eye Res       Date:  1989-05       Impact factor: 3.467

3.  Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Alexander Sumaroka; Sharon B Schwartz; Elaine E Smilko; Ann H Milam; Val C Sheffield; Edwin M Stone
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

4.  Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype.

Authors:  Sharon B Schwartz; Tomas S Aleman; Artur V Cideciyan; Elizabeth A M Windsor; Alexander Sumaroka; Alejandro J Roman; Tej Rane; Elaine E Smilko; Jean Bennett; Edwin M Stone; William J Kimberling; Xue-Zhong Liu; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

5.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Elise Heon; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

7.  Visual acuity loss in patients with Usher's syndrome.

Authors:  L Piazza; G A Fishman; M Farber; D Derlacki; R J Anderson
Journal:  Arch Ophthalmol       Date:  1986-09

8.  A FERM domain autoregulates Drosophila myosin 7a activity.

Authors:  Yi Yang; Thomas G Baboolal; Verl Siththanandan; Michael Chen; Matthew L Walker; Peter J Knight; Michelle Peckham; James R Sellers
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

9.  Kinetics of visual field loss in Usher syndrome Type II.

Authors:  Alessandro Iannaccone; Stephen B Kritchevsky; Maria Laura Ciccarelli; Salvatore A Tedesco; Claudio Macaluso; William J Kimberling; Grant W Somes
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-03       Impact factor: 4.799

10.  Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B.

Authors:  T Hashimoto; D Gibbs; C Lillo; S M Azarian; E Legacki; X-M Zhang; X-J Yang; D S Williams
Journal:  Gene Ther       Date:  2007-02-01       Impact factor: 4.184

View more
  25 in total

1.  Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A.

Authors:  Frank M Dyka; Sanford L Boye; Vince A Chiodo; William W Hauswirth; Shannon E Boye
Journal:  Hum Gene Ther Methods       Date:  2014-04       Impact factor: 2.396

Review 2.  Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A.

Authors:  Vanda S Lopes; David S Williams
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-20       Impact factor: 6.915

3.  Cone responses in Usher syndrome types 1 and 2 by microvolt electroretinography.

Authors:  Wadih M Zein; Benedetto Falsini; Ekaterina T Tsilou; Amy E Turriff; Julie M Schultz; Thomas B Friedman; Carmen C Brewer; Christopher K Zalewski; Kelly A King; Julie A Muskett; Atteeq U Rehman; Robert J Morell; Andrew J Griffith; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-25       Impact factor: 4.799

4.  Molecular Heterogeneity Within the Clinical Diagnosis of Pericentral Retinal Degeneration.

Authors:  Rodrigo Matsui; Artur V Cideciyan; Sharon B Schwartz; Alexander Sumaroka; Alejandro J Roman; Malgorzata Swider; Wei Chieh Huang; Rebecca Sheplock; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

5.  Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations.

Authors:  Alejandro J Roman; Artur V Cideciyan; Sharon B Schwartz; Melani B Olivares; Elise Heon; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-15       Impact factor: 4.799

6.  Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.

Authors:  Artur V Cideciyan; Samuel G Jacobson; William A Beltran; Alexander Sumaroka; Malgorzata Swider; Simone Iwabe; Alejandro J Roman; Melani B Olivares; Sharon B Schwartz; András M Komáromy; William W Hauswirth; Gustavo D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

7.  Myosin 6 is required for iris development and normal function of the outer retina.

Authors:  Ivy S Samuels; Brent A Bell; Gwen Sturgill-Short; Lindsey A Ebke; Mary Rayborn; Lanying Shi; Patsy M Nishina; Neal S Peachey
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-01       Impact factor: 4.799

8.  Drusen and photoreceptor abnormalities in African-Americans with intermediate non-neovascular age-related macular degeneration.

Authors:  Sam Sadigh; Xunda Luo; Artur V Cideciyan; Alexander Sumaroka; Stacy L Boxley; Laura M Hall; Rebecca Sheplock; William J Feuer; Dwight S Stambolian; Samuel G Jacobson
Journal:  Curr Eye Res       Date:  2014-06-09       Impact factor: 2.424

9.  Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.

Authors:  Jason Charng; Artur V Cideciyan; Samuel G Jacobson; Alexander Sumaroka; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Rebecca Sheplock; Manisha Anand; Marc C Peden; Hemant Khanna; Elise Heon; Alan F Wright; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

Review 10.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.